CDKN2A and malignant colon neoplasm: As expected, the expression levels of P16INK4A and P14ARF were significantly higher in the P14AS expression-positive (+) samples than in the P14AS expression-negative (−) samples only within the CBX7 high colon cancer group, but not within the CBX7 low colon cancer group (Figure 5A).